| Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled … L Kappos, JS Wolinsky, G Giovannoni, DL Arnold, Q Wang, C Bernasconi, ... JAMA neurology 77 (9), 1132-1140, 2020 | 452 | 2020 |
| Prospective age‐matching in elderly kidney transplant recipients—a 5‐year analysis of the Eurotransplant Senior Program U Frei, J Noeldeke, V Machold‐Fabrizii, H Arbogast, R Margreiter, ... American Journal of Transplantation 8 (1), 50-57, 2008 | 442 | 2008 |
| Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation H Ekberg, C Bernasconi, H Tedesco-Silva, S Vítko, C Hugo, A Demirbas, ... American journal of transplantation 9 (8), 1876-1885, 2009 | 414 | 2009 |
| Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled … M Dougados, K Kissel, T Sheeran, PP Tak, PG Conaghan, EM Mola, ... Annals of the rheumatic diseases 72 (1), 43-50, 2013 | 409 | 2013 |
| Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data GA Knoll, MB Kokolo, R Mallick, A Beck, CD Buenaventura, R Ducharme, ... Bmj 349, 2014 | 358 | 2014 |
| Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial JWJ Bijlsma, PMJ Welsing, TG Woodworth, LM Middelink, ... The Lancet 388 (10042), 343-355, 2016 | 289 | 2016 |
| Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions C Elliott, JS Wolinsky, SL Hauser, L Kappos, F Barkhof, C Bernasconi, ... Multiple Sclerosis Journal 25 (14), 1915-1925, 2019 | 211 | 2019 |
| Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis C Elliott, S Belachew, JS Wolinsky, SL Hauser, L Kappos, F Barkhof, ... Brain 142 (9), 2787-2799, 2019 | 207 | 2019 |
| On the directionality of cortical interactions studied by structural analysis of electrophysiological recordings C Bernasconi, P KoÈnig Biological cybernetics 81 (3), 199-210, 1999 | 198 | 1999 |
| Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials R Bouamar, N Shuker, DA Hesselink, W Weimar, H Ekberg, B Kaplan, ... American Journal of Transplantation 13 (5), 1253-1261, 2013 | 173 | 2013 |
| Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study M Dougados, K Kissel, PG Conaghan, EM Mola, G Schett, R Gerli, ... Annals of the rheumatic diseases 73 (5), 803-809, 2014 | 167 | 2014 |
| Direct mechanical intervention versus combined intravenous and mechanical intervention in large artery anterior circulation stroke: a matched-pairs analysis A Broeg-Morvay, P Mordasini, C Bernasconi, M Bühlmann, F Pult, ... Stroke 47 (4), 1037-1044, 2016 | 164 | 2016 |
| Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study H Ekberg, C Bernasconi, J Nöldeke, A Yussim, L Mjörnstedt, U Erken, ... Nephrology Dialysis Transplantation 25 (6), 2004-2010, 2010 | 141 | 2010 |
| Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study TWJ Huizinga, PG Conaghan, E Martin-Mola, G Schett, H Amital, ... Annals of the Rheumatic Diseases 74 (1), 35-43, 2015 | 137 | 2015 |
| Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice VP Bykerk, AJK Östör, J Alvaro-Gracia, K Pavelka, JAR Ivorra, ... Annals of the rheumatic diseases 71 (12), 1950-1954, 2012 | 132 | 2012 |
| Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis JD Isaacs, O Harari, U Kobold, JS Lee, C Bernasconi Arthritis research & therapy 15, 1-6, 2013 | 123 | 2013 |
| Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised … GR Burmester, F Buttgereit, C Bernasconi, JM Álvaro-Gracia, N Castro, ... The Lancet 396 (10246), 267-276, 2020 | 119 | 2020 |
| Adherence and satisfaction of smartphone-and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional … L Midaglia, P Mulero, X Montalban, J Graves, SL Hauser, L Julian, ... Journal of medical Internet research 21 (8), e14863, 2019 | 119 | 2019 |
| Risk stratification for rejection and infection after kidney transplantation PE Cippà, M Schiesser, H Ekberg, T van Gelder, NJ Mueller, CA Cao, ... Clinical Journal of the American Society of Nephrology 10 (12), 2213-2220, 2015 | 107 | 2015 |
| Direct mechanical intervention versus bridging therapy in stroke patients eligible for intravenous thrombolysis: a pooled analysis of 2 registries S Bellwald, R Weber, T Dobrocky, H Nordmeyer, S Jung, J Hadisurya, ... Stroke 48 (12), 3282-3288, 2017 | 101 | 2017 |
